Global equity funds attracted significant inflows in the week ending February 12, after a Bank of England rate cut drove a ...
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
AstraZeneca’s ( www.AstraZeneca.com) flagship health equity programme - Healthy Heart Africa (HHA), marks its 10th ...
A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...
Hedge fund Citadel has made a 305 million pound ($384.5 million) bet against drugmaker GSK , the Financial Times reported on ...
23h
Hosted on MSNUBS Upgrades AstraZeneca PLC - Depositary Receipt () (AZN)Fintel reports that on February 13, 2025, UBS upgraded their outlook for AstraZeneca PLC - Depositary Receipt () ...
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Havant MP Alan Mak has demanded to know why the Labour Government chose to walk away from a £450m investment deal with ...
Alexion, AstraZeneca Rare Disease and DHL Express have teamed up to initiate Ireland's “first” complete transition to SAF ...
Sumitomo Mitsui Trust Group Inc. grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & ...
Mediaplanet today announces the launch of Lung Health. Chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and other lung conditions affect millions worldwide, yet many remain unaware ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results